Abiraterone-induced rhabdomyolysis: A case report

2016 ◽  
Vol 23 (2) ◽  
pp. 148-151 ◽  
Author(s):  
Donald C Moore ◽  
Andrew Moore

Abiraterone is an inhibitor of androgen biosynthesis indicated for the treatment of metastatic castration-resistant prostate cancer. Common side effects include diarrhea, edema, hypokalemia, hypertension, and liver function test abnormalities. We report a case of rhabdomyolysis developing in association with the use of abiraterone. Following discontinuation of abiraterone, creatine kinase concentrations decreased gradually throughout the duration of the hospitalization.

PM&R ◽  
2011 ◽  
Vol 3 ◽  
pp. S339-S339
Author(s):  
Mohsen Tahani ◽  
Adrian Didita ◽  
Jenny Lee ◽  
John Seno

2016 ◽  
Vol 14 (5) ◽  
pp. e529-e533 ◽  
Author(s):  
Giuseppe De Vincentis ◽  
Giulia Anna Follacchio ◽  
Viviana Frantellizzi ◽  
Mauro Liberatore ◽  
Francesco Monteleone ◽  
...  

2019 ◽  
Vol 17 (1) ◽  
pp. e61-e64 ◽  
Author(s):  
Aline Bobato Lara Gongora ◽  
Felipe Sales Nogueira Amorim Canedo ◽  
André Luis Alves de Melo ◽  
Regis Otaviano Franca Bezerra ◽  
Paula Fontes Asprino ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document